FDA advisers back Pfizer’s COVID-19 vaccine for young kidsFDA advisers back Pfizer’s COVID-19 vaccine for young kidsFDA advisers back Pfizer’s COVID-19 vaccine for young kids

FDA advisers back Pfizer’s COVID-19 vaccine for young kids

A panel of U.S. health advisers endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.

from Section Page News - Modern Healthcare https://ift.tt/3nzl8hg